OBJECTIVE: This study evaluated the concordance between the self-report and the clinician-rated versions of the Inventory of Depressive Symptomatology (IDS-30) and between the two versions of the briefer 16-item Quick Inventory of Depressive Symptomatology (QIDS-16). METHODS: Data were gathered for 544 adult outpatients with psychotic (N = 106) or nonpsychotic (N = 438) major depressive disorder at 14 public sector mental health clinics in the Texas Medication Algorithm Project. Data for the QIDS-16 were extracted from the IDS-30. Baseline scores and scores from the final study visit at or before month 12 were analyzed. The clinician-rated and the self-report versions of each scale were compared in their identification of response to treatment and remission. RESULTS: The average baseline IDS-SR-30 total score was 2.2 points higher (indicating greater severity) than the IDS-C-30 score; the average QIDS-SR-16 total score was only .3 points higher than the QIDS-C-16 score. The IDS-SR-30 and the IDS-C-30, as well as the QIDS-C-16 and QIDS-SR-16, agreed substantially in classifying response and remission for patients, regardless of whether the patients had psychotic features. None of a large number of clinical and demographic features accounted for differences between the QIDS-SR-16 and QIDS-C-16 total scores. CONCLUSIONS: Either the IDS-30 or the QIDS-16 self-report adequately assesses depressive symptom severity among public-sector outpatients with major depressive disorder. The briefer QIDS-16 may be preferred to save time and cost.
OBJECTIVE: This study evaluated the concordance between the self-report and the clinician-rated versions of the Inventory of Depressive Symptomatology (IDS-30) and between the two versions of the briefer 16-item Quick Inventory of Depressive Symptomatology (QIDS-16). METHODS: Data were gathered for 544 adult outpatients with psychotic (N = 106) or nonpsychotic (N = 438) major depressive disorder at 14 public sector mental health clinics in the Texas Medication Algorithm Project. Data for the QIDS-16 were extracted from the IDS-30. Baseline scores and scores from the final study visit at or before month 12 were analyzed. The clinician-rated and the self-report versions of each scale were compared in their identification of response to treatment and remission. RESULTS: The average baseline IDS-SR-30 total score was 2.2 points higher (indicating greater severity) than the IDS-C-30 score; the average QIDS-SR-16 total score was only .3 points higher than the QIDS-C-16 score. The IDS-SR-30 and the IDS-C-30, as well as the QIDS-C-16 and QIDS-SR-16, agreed substantially in classifying response and remission for patients, regardless of whether the patients had psychotic features. None of a large number of clinical and demographic features accounted for differences between the QIDS-SR-16 and QIDS-C-16 total scores. CONCLUSIONS: Either the IDS-30 or the QIDS-16 self-report adequately assesses depressive symptom severity among public-sector outpatients with major depressive disorder. The briefer QIDS-16 may be preferred to save time and cost.
Authors: Carroll W Hughes; Madhukar H Trivedi; Joseph Cleaver; Tracy L Greer; Graham J Emslie; Beth Kennard; Shauna Dorman; Tyson Bain; Judy Dubreuil; Conrad Barnes Journal: Ment Health Phys Act Date: 2009-12
Authors: Boadie W Dunlop; Thomas Li; Susan G Kornstein; Edward S Friedman; Anthony J Rothschild; Ron Pedersen; Philip Ninan; Martin Keller; Madhukar H Trivedi Journal: J Psychiatr Res Date: 2010-06-02 Impact factor: 4.791
Authors: Katherine E Watkins; Sarah B Hunter; Kimberly A Hepner; Susan M Paddock; Erin de la Cruz; Annie J Zhou; Jim Gilmore Journal: Arch Gen Psychiatry Date: 2011-06
Authors: Katherine E Watkins; Alison E Cuellar; Kimberly A Hepner; Sarah B Hunter; Susan M Paddock; Brett A Ewing; Erin de la Cruz Journal: J Subst Abuse Treat Date: 2013-10-02
Authors: T Michael Kashner; Madhukar H Trivedi; Annie Wicker; Maurizio Fava; Stephen R Wisniewski; A John Rush Journal: CNS Neurosci Ther Date: 2009-08-27 Impact factor: 5.243
Authors: Cindy Claassen; Ben Kurian; Madhukar H Trivedi; Bruce D Grannemann; Ekta Tuli; Ronny Pipes; Anne Marie Preston; Ariell Flood Journal: Contemp Clin Trials Date: 2008-08-12 Impact factor: 2.226
Authors: Noah S Philip; S Louisa Carpenter; Samuel J Ridout; George Sanchez; Sarah E Albright; Audrey R Tyrka; Lawrence H Price; Linda L Carpenter Journal: J Affect Disord Date: 2015-07-17 Impact factor: 4.839